Differentiating agents do not induce a true hairy cell phenotype in B-CLL cells in vitro

被引：1
|
作者：
Gartenhaus, R [1 ]
Hoffman, M [1 ]
Fuchs, A [1 ]
Billet, H [1 ]
Wang, P [1 ]
Gentile, P [1 ]
Rai, K [1 ]
机构：
[1] LONG ISL JEWISH MED CTR,DEPT MED,DIV HEMATOL ONCOL,NEW HYDE PK,NY 11042
来源：
LEUKEMIA & LYMPHOMA | 1996年 / 22卷 / 1-2期
关键词：
chronic lymphocytic leukemia (CLL); hairy cell leukemia (HCL); differentiating agents; phorbol esters; lactones; retinoids;
D O I：
10.3109/10428199609051734
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B-Chronic lymphocytic leukemia (B-CLL) and hairy cell leukemia (HCL) are both differentiated B-cell lymphoproliferative disorders. Prior studies have suggested that phorbol esters and the macrocyclic lactone Bryostatin-1, which are both protein kinase-C activators, can induce the differentiation of B-CLL cells into HCL cells in vitro, as evidenced by morphology, phenotype and TRAP activity. The differentiating effect of all-trans retinoic acid on B-CLL cells has been less extensively studied. We studied the effects of incubating adherence purified B-CLL cells with phorbol myristic acetate (PMA), all-trans retinoic acid (ATRA), and Bryostatin-1. None of these agents induced a true HCL phenotype (CD5-, CD11c/CD25 coexpression) under the conditions studied.
引用
收藏
页码：97 / &
页数：6
相关论文
共 50 条
  • [1] The accessory cell function of B-CLL B cells
    Campagna, KJ
    Chiorazzi, N
    Chang, MDY
    B LYMPHOCYTES AND AUTOIMMUNITY, 1997, 815 : 427 - 431
  • [2] Evaluation of taxol cytotoxicity on B-CLL cells in vitro
    DiRaimondo, F
    Palumbo, GA
    Romeo, MA
    Galvagno, F
    Stagno, F
    Morabito, F
    Giustolisi, R
    LEUKEMIA & LYMPHOMA, 1997, 26 (1-2) : 115 - 119
  • [3] Treatment of B-CLL cells with bortezomib and rituximab reduces cell viability in vitro
    Lewintre, EJ
    Sarsotti, E
    Terol, MJ
    Benet, I
    Martinez-Climent, JA
    Garcia-Conde, J
    BLOOD, 2004, 104 (11) : 765A - 766A
  • [4] Inhibition of T cell/B cell interaction by B-CLL cells
    C Kneitz
    M Goller
    M Wilhelm
    C Mehringer
    G Wohlleben
    A Schimpl
    H-P Tony
    Leukemia, 1999, 13 : 98 - 104
  • [5] Inhibition of T cell B cell interaction by B-CLL cells
    Kneitz, C
    Goller, M
    Wilhelm, M
    Mehringer, C
    Wohlleben, G
    Schimpl, A
    Tony, HP
    LEUKEMIA, 1999, 13 (01) : 98 - 104
  • [6] In vitro evaluation of B-CLL cells apoptotic responses to irradiation
    Comby, E
    Andre, I
    Troussard, X
    Lebrun, E
    Sola, B
    Ballet, JJ
    Leporrier, M
    LEUKEMIA & LYMPHOMA, 1999, 34 (1-2) : 159 - 166
  • [7] CYTOKINE REGULATION OF APOPTOSIS OF B-CLL CELLS IN-VITRO
    JEWELL, AP
    WORMAN, CP
    GILES, FJ
    LYDYARD, PM
    GOLDSTONE, AH
    BLOOD, 1993, 82 (10) : A567 - A567
  • [8] IN-VITRO SENSITIVITY OF B-CLL CELLS TO FLUDARABINE AND INTERFERONS
    DIRAIMONDO, F
    GUGLIELMO, P
    PALUMBO, GA
    CACCIOLA, E
    GIUSTOLISI, R
    CACCIOLA, E
    BLOOD, 1993, 82 (10) : A563 - A563
  • [9] IN-VITRO SENSITIVITY OF B-CLL CELLS TO FLUDARABINE AND INTERFERONS
    DIRAIMONDO, F
    PALUMBO, GA
    ROMEO, MA
    CACCIOLA, E
    MILONE, G
    IMPERA, S
    GIUSTOLISI, R
    CACCIOLA, E
    LEUKEMIA & LYMPHOMA, 1995, 17 (5-6) : 449 - 453
  • [10] Apoptosis of B-CLL cells in vivo and in vitro: Effect of autologous serum, B- and T-cells on apoptosis of malignant B-CLL cells.
    Bomstein, Y
    Yuklea, M
    Yarkoni, S
    Radnay, J
    Shapiro, H
    Afanasyev, F
    Lishner, M
    BLOOD, 2000, 96 (11) : 270B - 271B
12345